Pneumonia is one of the most common diseases in children, which occupies a leading place in the structure of morbidity and mortality from infectious diseases, which is manifested by symptoms of respiratory failure. Since the main pathogenetic link is the formation of inflammation with damage to the lobe of the lung, its segment or group of alveoli, as well as the interalveolar space, we carried out treatment with antibacterial and antiviral drugs. We have treated 60 patients aged 3 to 15 years, who were divided into 2 groups. The patients were hospitalized at the Samarkand Branch of the Republican Scientific Center for Emergency Medical Aid, in the departments of pediatrics. 30 patients were prescribed complex therapy, which included the antibacterial drug Clarithromycin, the antiviral drug na-soferon in an age-related dosage for 10 days. Clinical manifestations of group I, who received the drug, were stopped almost 2 times faster than in patients from group II. Complex treatment of antibiotics and antiviral drugs for community-acquired pneumonia with atypical etiology has shown that they are the most effective, preventing and reducing the severity of pneumonia.